Recombinant human growth hormone treatment in children with thalassemia major

Arcasoy, A; Ocal, G; Kemahli, S; BERBEROĞLU, MERİH; Yildirmak, Y; Canatan, D; Akcurin, S; Akar, N; Uysal, Z; Adiyaman, P; Cetinkaya, E

doi:10.1046/j.1442-200x.1999.t01-1-01139.x

Recombinant human growth hormone treatment in children with thalassemia major

Arcasoy A., Ocal G., Kemahli S., BERBEROĞLU M., Yildirmak Y., Canatan D., ...Daha Fazla

PEDIATRICS INTERNATIONAL, cilt.41, sa.6, ss.655-661, 1999 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 41 Sayı: 6
Basım Tarihi: 1999
Doi Numarası: 10.1046/j.1442-200x.1999.t01-1-01139.x
Dergi Adı: PEDIATRICS INTERNATIONAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.655-661
Anahtar Kelimeler: growth hormone, growth retardation, thalassemia, INSULIN-LIKE ACTIVITY, GH-RELEASING HORMONE, BETA-THALASSEMIA, LINEAR GROWTH, FACTOR-I, SECRETION, DEFICIENCY
Ankara Üniversitesi Adresli: Evet

Özet

Background: To evaluate the growth hormone reserve and the growth hormone response to recombinant human growth hormone (GH) in prepubertal thalassemic children with growth retardation.